Skip to main content
Fig. 6 | EJNMMI Research

Fig. 6

From: Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab

Fig. 6

The effect of rapamycin therapy on VEGF levels in FaDu xenografts. a Changes in VEGF levels as measured by ELISA. Differences in levels were not statistically significant. b Changes in VEGF isoforms assessed by Western blot in FaDu xenografts treated with either rapamycin (20 mg/kg/day) or vehicle control for 10 days. c Changes in VEGF isoforms were measured using densitometry in the corresponding blots. Data are presented as mean ± SEM, **P < 0.01, n = 11/group

Back to article page